Celularity CELU
NASDAQ CELU
$0.96 -0.09 (-8.51%)
As of: Oct 23, 2026 · 3:59 PM EDT

Celularity (CELU) Interest Coverage Ratio (2025 - 2026)

Updated

Celularity's Interest Coverage Ratio came in at -23.94 for Q2 2026, compared with -8.16 a year earlier.

Analysis

Celularity (CELU) Interest Coverage Ratio (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Celularity reported Interest Coverage Ratio of -10.05.

  • The five-year range for quarterly Interest Coverage Ratio is -28.79 (Q1 2026) to -4.30 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 28.50
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 10.28
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 7.27
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -42.08
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -
10 Celularity 28.25 Mn 21.00 Mn 3.09 Mn -23.94
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.94
Mar 31, 2026 -28.79
Mar 31, 2025 -4.30
API Access

Celularity Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CELU&period=max&api_key=YOUR_API_KEY